CLINICAL_TRIALS
trial_result
· 2026-04-20
Clinical Trial Update: Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008) [Phase 2]
Summary
A Phase 2 study is evaluating Sotatercept (MK-7962) in children with pulmonary arterial hypertension. The trial is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: RECRUITING